Global Information
회사소개 | 문의 | 비교리스트

공캡슐 시장 : 제품, 원료, 약제 용도, 최종사용자별 - 세계 기회 분석 및 산업 예측(2021-2030년)

Empty Capsules Market by Product, Raw Material, Therapeutic Application, and End User : Global Opportunity Analysis and Industry Forecast, 2021--2030

리서치사 Allied Market Research
발행일 2021년 12월 상품코드 1059614
페이지 정보 영문 290 Pages 배송안내 2-3일 (영업일 기준)
가격
US $ 4,125 ₩ 5,310,000 Excel (Data Pack) help
DRM(디지털 저작권 관리 시스템) 장착 Excel 파일로, 1명만 이용할 수 있는 라이선스입니다. 인쇄는 1회에 한해 가능합니다. 인쇄물 이용은 Excel파일 라이선스 소유자로 한정됩니다.
US $ 6,168 ₩ 7,940,000 PDF (Single User License + Covid impact) help
DRM(디지털 저작권 관리 시스템) 장착 PDF 파일로, 1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste 가 되지 않으며, 인쇄는 1회에 한해 가능합니다. 인쇄물 이용은 PDF 라이선스 소유자로 한정됩니다.
US $ 6,929 ₩ 8,919,000 PDF (5-user License) help
DRM(디지털 저작권 관리 시스템) 장착 PDF 파일로, 5명까지 이용할 수 있는 라이선스입니다. 인쇄는 5회까지 가능하며 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 10,663 ₩ 13,726,000 PDF (Enterprise User License) help
동일 기업 내의 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수 제한은 없습니다. PDF 파일은 Copy & Paste 가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.

주의 : 본 보고서는 DRM(디지털 저작권 관리 시스템)이 장착된 PDF 파일로, 라이선스에 따라 자료 이용 및 인쇄 등에 제약이 있을 수 있습니다. 자세한 내용은 라이선스 설명문( )을 참고하여 주시기 바랍니다.



공캡슐 시장 : 제품, 원료, 약제 용도, 최종사용자별 - 세계 기회 분석 및 산업 예측(2021-2030년) Empty Capsules Market by Product, Raw Material, Therapeutic Application, and End User : Global Opportunity Analysis and Industry Forecast, 2021--2030
발행일 : 2021년 12월 페이지 정보 : 영문 290 Pages

본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 공캡슐 시장 규모는 2020년 23억 8,270만 달러에서 예측 기간 중 8.1%의 CAGR로 추이하며, 2030년에는 52억 3,040만 달러 규모로 성장할 것으로 예측됩니다.

세계 공캡슐 시장의 성장은 주로 암, 심혈관질환, 당뇨병, 소화기 질환 등 만성질환 유병률의 대폭적인 증가, 뉴트라슈티컬 제품의 인지도와 이점을 촉진하기 위한 정부 구상의 증가, 캡슐 생산 수의 급증, 휴먼 헬스케어 서비스에 대한 지출의 증가, 젤라틴 캡슐의 채택률의 상승 등에 의해 추진되고 있습니다. 또한 노년 인구의 증가, 비타민 & 미네랄 보충제에 대한 수요의 급증, 제약 부문의 개발 증가, 면역 부스터 보충제에 대한 요구의 급증 등도 시장의 성장을 지원하고 있습니다.

세계의 공캡슐 시장을 조사했으며, 시장의 정의와 개요, 시장 영향요인 분석, 시장 규모의 추이·예측, 제품·원료·약제 용도·최종사용자·지역/주요 국가 등 각종 부문별 내역, 경쟁 환경, 주요 기업의 개요 등을 정리하여 전해드립니다.

목차

제1장 서론

제2장 개요

제3장 시장 개요

  • 시장의 정의·범위
  • 주요 조사 결과
  • Porter의 산업 분석
  • 주요 기업의 포지셔닝
  • 시장 역학
    • 촉진요인
    • 억제요인
    • 시장 기회
    • 영향 분석
  • COVID-19 : 영향 분석

제4장 공캡슐 시장 : 제품별

  • 개요
  • 주요 시장 동향·성장요인·기회
  • 시장 규모·예측 : 지역별
  • 시장 분석 : 국가별
  • 젤라틴 캡슐
    • 하드 젤라틴 캡슐(HGC)
    • 소프트 젤라틴 캡슐(SGC)
  • 비젤라틴 캡슐

제5장 공캡슐 시장 : 원료별

  • 개요
  • 돼지고기
  • 소고기
  • HPMC(Hydroxypropyl methylcellulose)
  • 기타
    • 주요 시장 동향·성장요인·기회
    • 시장 규모·예측 : 지역별
    • 시장 분석 : 국가별

제6장 공캡슐 시장 : 약제 용도별

  • 개요
  • 항생제·항균제
  • 비타민·식이보충제
  • 제산제·정장제
  • 심장 치료제
  • 기타
    • 주요 시장 동향·성장요인·기회
    • 시장 규모·예측 : 지역별
    • 시장 분석 : 국가별

제7장 공캡슐 시장 : 최종사용자별

  • 개요
  • 제약기업
  • 뉴트라슈티컬 제조업체
  • 기타
    • 주요 시장 동향·성장요인·기회
    • 시장 규모·예측 : 지역별
    • 시장 분석 : 국가별

제8장 공캡슐 시장 : 지역별

  • 개요
  • 북미
  • 유럽
  • 아시아태평양
  • 라틴아메리카·중동·아프리카
    • 주요 시장 동향·성장요인·기회
    • 공캡슐 시장 : 제품별
    • 공캡슐 시장 : 원료별
    • 공캡슐 시장 : 약제 용도별
    • 공캡슐 시장 : 최종사용자별
    • 시장 규모·예측 : 국가별

제9장 기업 개요

  • ACG Worldwide
  • Bright Pharma Caps Inc.
  • CapsCanada Corporation
  • Lonza Group Ltd.(Capsugel)
  • Medi-Caps Limited
  • Mitsubishi Chemical Holdings Corporation(Qualicaps, Inc.)
  • Roxlor LLC
  • Snail Pharma Industry Co. Ltd.
  • Suheung Co., Ltd.
  • Sunil Healthcare Ltd.
KSA 22.03.08

LIST OF TABLES

  • TABLE 01.EMPTY CAPSULE MARKET, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 02.GELATIN CAPSULE MARKET, BY TYPE, 2020-2030 ($MILLION)
  • TABLE 03.GELATIN CAPSULE MARKET, BY REGION, 2020-2030 ($MILLION)
  • TABLE 04.NON-GELATIN CAPSULE MARKET, BY REGION, 2020-2030 ($MILLION)
  • TABLE 05.EMPTY CAPSULE MARKET, BY RAWMATERIAL, 2020-2030 ($MILLION)
  • TABLE 06.EMPTY CAPSULE MARKET FOR PIG MEAT, BY REGION, 2020-2030 ($MILLION)
  • TABLE 07.EMPTY CAPSULE MARKET FORBOVINE MEAT, BY REGION, 2020-2030 ($MILLION)
  • TABLE 08.EMPTY CAPSULE MARKET FORBONE, BY REGION, 2020-2030 ($MILLION)
  • TABLE 09.EMPTY CAPSULE MARKET FORHYDROXYPROPYL METHYLCELLULOSE (HPMC), BY REGION, 2020-2030 ($MILLION)
  • TABLE 10.EMPTY CAPSULE MARKET FOROTHERS, BY REGION, 2020-2030 ($MILLION)
  • TABLE 11.EMPTY CAPSULE MARKET, BY THERAPEUTIC APPLICATION, 2020-2030 ($MILLION)
  • TABLE 12.EMPTY CAPSULE MARKET FOR ANTIBIOTIC & ANTIBACTERIAL DRUGS, BY REGION, 2020-2030 ($MILLION)
  • TABLE 13.EMPTY CAPSULE MARKET FOR VITAMIN & DIETARY SUPPLEMENTS, BY REGION, 2020-2030 ($MILLION)
  • TABLE 14.EMPTY CAPSULE MARKET FOR ANTACIDS & ANTI-FLATULENT PREPARATIONS, BY REGION, 2020-2030 ($MILLION)
  • TABLE 15.EMPTY CAPSULE MARKET FOR CARDIAC THERAPY DRUGS, BY REGION, 2020-2030 ($MILLION)
  • TABLE 16.EMPTY CAPSULE MARKET FOR OTHERS, BY REGION, 2020-2030 ($MILLION)
  • TABLE 17.EMPTY CAPSULE MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 18.EMPTY CAPSULE MARKET FOR PHARMACEUTICAL MANUFACTURERS, BY REGION, 2020-2030 ($MILLION)
  • TABLE 19.EMPTY CAPSULE MARKET FOR NUTRACEUTICAL MANUFACTURERS, BY REGION, 2020-2030 ($MILLION)
  • TABLE 20.EMPTY CAPSULE MARKET FOR OTHERS, BY REGION, 2020-2030 ($MILLION)
  • TABLE 21.EMPTY CAPSULE MARKET, BY REGION, 2020-2030 ($MILLION)
  • TABLE 22.NORTH AMERICA EMPTY CAPSULE MARKET, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 23.NORTH AMERICA EMPTYCAPSULE MARKET, BY RAW MATERIAL, 2020-2030 ($MILLION)
  • TABLE 24.NORTH AMERICA EMPTY CAPSULE MARKET, BY THERAPEUTIC APPLICATION, 2020-2030 ($MILLION)
  • TABLE 25.NORTH AMERICA EMPTY CAPSULE MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 26.NORTH AMERICA EMPTYCAPSULE MARKET, BY COUNTRY, 2020-2030 ($MILLION)
  • TABLE 27.U.S. EMPTY CAPSULE MARKET, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 28.U.S. EMPTY CAPSULE MARKET, BY RAW MATERIAL,2020-2030 ($MILLION)
  • TABLE 29.U.S. EMPTY CAPSULE MARKET, BY THERAPEUTIC APPLICATION, 2020-2030 ($MILLION)
  • TABLE 30.U.S. EMPTY CAPSULE MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 31.CANADA EMPTY CAPSULE MARKET, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 32.CANADA EMPTY CAPSULE MARKET, BY RAW MATERIAL,2020-2030 ($MILLION)
  • TABLE 33.CANADA EMPTY CAPSULE MARKET, BY THERAPEUTIC APPLICATION, 2020-2030 ($MILLION)
  • TABLE 34.CANADA EMPTY CAPSULE MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 35.MEXICO EMPTY CAPSULE MARKET, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 36.MEXICOEMPTY CAPSULE MARKET, BY RAW MATERIAL,2020-2030 ($MILLION)
  • TABLE 37.MEXICO EMPTY CAPSULE MARKET, BY THERAPEUTIC APPLICATION, 2020-2030 ($MILLION)
  • TABLE 38.MEXICO EMPTY CAPSULE MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 39.EUROPE EMPTY CAPSULE MARKET, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 40.EUROPE EMPTY CAPSULE MARKET, BY RAW MATERIAL, 2020-2030 ($MILLION)
  • TABLE 41.EUROPE EMPTY CAPSULE MARKET, BY THERAPEUTIC APPLICATION, 2020-2030 ($MILLION)
  • TABLE 42.EUROPE EMPTY CAPSULE MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 43.EUROPE EMPTY CAPSULE MARKET, BY COUNTRY, 2020-2030 ($MILLION)
  • TABLE 44.GERMANY EMPTY CAPSULE MARKET, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 45.GERMANY EMPTY CAPSULE MARKET, BY RAW MATERIAL,2020-2030 ($MILLION)
  • TABLE 46.GERMANY EMPTY CAPSULE MARKET, BY THERAPEUTIC APPLICATION, 2020-2030 ($MILLION)
  • TABLE 47.GERMANY EMPTY CAPSULE MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 48.FRANCE EMPTY CAPSULE MARKET, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 49.FRANCE EMPTY CAPSULE MARKET, BY RAW MATERIAL,2020-2030 ($MILLION)
  • TABLE 50.FRANCE EMPTY CAPSULE MARKET, BY THERAPEUTIC APPLICATION, 2020-2030 ($MILLION)
  • TABLE 51.FRANCE EMPTY CAPSULE MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 52.UK EMPTY CAPSULE MARKET, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 53.UK EMPTY CAPSULE MARKET, BY RAW MATERIAL,2020-2030 ($MILLION)
  • TABLE 54.UK EMPTY CAPSULE MARKET, BY THERAPEUTIC APPLICATION, 2020-2030 ($MILLION)
  • TABLE 55.UK EMPTY CAPSULE MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 56.ITALY EMPTY CAPSULE MARKET, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 57.ITALY EMPTY CAPSULE MARKET, BY RAW MATERIAL,2020-2030 ($MILLION)
  • TABLE 58.ITALYEMPTY CAPSULE MARKET, BY THERAPEUTIC APPLICATION, 2020-2030 ($MILLION)
  • TABLE 59.ITALY EMPTY CAPSULE MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 60.SPAIN EMPTY CAPSULE MARKET, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 61.SPAIN EMPTY CAPSULE MARKET, BY RAW MATERIAL,2020-2030 ($MILLION)
  • TABLE 62.SPAIN EMPTY CAPSULE MARKET, BY THERAPEUTIC APPLICATION, 2020-2030 ($MILLION)
  • TABLE 63.SPAIN EMPTY CAPSULE MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 64.REST OF EUROPE EMPTY CAPSULE MARKET, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 65.REST OF EUROPE EMPTY CAPSULE MARKET, BY RAW MATERIAL,2020-2030 ($MILLION)
  • TABLE 66.REST OF EUROPE EMPTY CAPSULE MARKET, BY THERAPEUTIC APPLICATION, 2020-2030 ($MILLION)
  • TABLE 67.REST OF EUROPE EMPTY CAPSULE MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 68.ASIA-PACIFIC EMPTY CAPSULE MARKET, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 69.ASIA-PACIFIC EMPTY CAPSULE MARKET, BY RAW MATERIAL, 2020-2030 ($MILLION)
  • TABLE 70.ASIA-PACIFIC EMPTY CAPSULE MARKET, BY THERAPEUTIC APPLICATION, 2020-2030 ($MILLION)
  • TABLE 71.ASIA-PACIFIC EMPTY CAPSULE MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 72.ASIA-PACIFIC EMPTY CAPSULE MARKET, BY COUNTRY, 2020-2030 ($MILLION)
  • TABLE 73.JAPAN EMPTY CAPSULE MARKET, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 74.JAPAN EMPTY CAPSULE MARKET, BY RAW MATERIAL,2020-2030 ($MILLION)
  • TABLE 75.JAPAN EMPTY CAPSULE MARKET, BY THERAPEUTIC APPLICATION, 2020-2030 ($MILLION)
  • TABLE 76.JAPAN EMPTY CAPSULE MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 77.CHINA EMPTY CAPSULE MARKET, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 78.CHINA EMPTY CAPSULE MARKET, BY RAW MATERIAL,2020-2030 ($MILLION)
  • TABLE 79.CHINA EMPTY CAPSULE MARKET, BY THERAPEUTIC APPLICATION, 2020-2030 ($MILLION)
  • TABLE 80.CHINA EMPTY CAPSULE MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 81.AUSTRALIA EMPTY CAPSULE MARKET, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 82.AUSTRALIA EMPTY CAPSULE MARKET, BY RAW MATERIAL,2020-2030 ($MILLION)
  • TABLE 83.AUSTRALIA EMPTY CAPSULE MARKET, BY THERAPEUTIC APPLICATION, 2020-2030 ($MILLION)
  • TABLE 84.AUSTRALIA EMPTY CAPSULE MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 85.INDIA EMPTY CAPSULE MARKET, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 86.INDIA EMPTY CAPSULE MARKET, BY RAW MATERIAL,2020-2030 ($MILLION)
  • TABLE 87.INDIA EMPTY CAPSULE MARKET, BY THERAPEUTIC APPLICATION, 2020-2030 ($MILLION)
  • TABLE 88.INDIA EMPTY CAPSULE MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 89.SOUTH KOREA EMPTY CAPSULE MARKET, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 90.SOUTH KOREA EMPTY CAPSULE MARKET, BY RAW MATERIAL,2020-2030 ($MILLION)
  • TABLE 91.SOUTH KOREA EMPTY CAPSULE MARKET, BY THERAPEUTIC APPLICATION, 2020-2030 ($MILLION)
  • TABLE 92.SOUTH KOREA EMPTY CAPSULE MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 93.REST OF ASIA-PACIFIC EMPTY CAPSULE MARKET, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 94.REST OF ASIA-PACIFIC EMPTY CAPSULE MARKET, BY RAW MATERIAL,2020-2030 ($MILLION)
  • TABLE 95.REST OF ASIA-PACIFIC EMPTY CAPSULE MARKET, BY THERAPEUTIC APPLICATION, 2020-2030 ($MILLION)
  • TABLE 96.REST OF ASIA-PACIFIC EMPTY CAPSULE MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 97.LAMEA EMPTY CAPSULE MARKET, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 98.LAMEA EMPTY CAPSULE MARKET, BY RAW MATERIAL, 2020-2030 ($MILLION)
  • TABLE 99.LAMEA EMPTY CAPSULE MARKET, BY THERAPEUTIC APPLICATION, 2020-2030 ($MILLION)
  • TABLE 100.LAMEA EMPTY CAPSULE MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 101.LAMEA EMPTY CAPSULE MARKET, BY COUNTRY, 2020-2030 ($MILLION)
  • TABLE 102.BRAZIL EMPTY CAPSULE MARKET, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 103.BRAZIL EMPTY CAPSULE MARKET, BY RAW MATERIAL,2020-2030 ($MILLION)
  • TABLE 104.BRAZIL EMPTY CAPSULE MARKET, BY THERAPEUTIC APPLICATION, 2020-2030 ($MILLION)
  • TABLE 105.BRAZIL EMPTY CAPSULE MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 106.SAUDI ARABIA EMPTY CAPSULE MARKET, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 107.SAUDI ARABIA EMPTY CAPSULE MARKET, BY RAW MATERIAL,2020-2030 ($MILLION)
  • TABLE 108.SAUDI ARABIA EMPTY CAPSULE MARKET, BY THERAPEUTIC APPLICATION, 2020-2030 ($MILLION)
  • TABLE 109.SAUDI ARABIA EMPTY CAPSULE MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 110.SOUTH AFRICA EMPTY CAPSULE MARKET, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 111.SOUTH AFRICA EMPTY CAPSULE MARKET, BY RAW MATERIAL,2020-2030 ($MILLION)
  • TABLE 112.SOUTH AFRICA EMPTY CAPSULE MARKET, BY THERAPEUTIC APPLICATION, 2020-2030 ($MILLION)
  • TABLE 113.SOUTH AFRICAEMPTY CAPSULE MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 114.REST OF LAMEA EMPTY CAPSULE MARKET, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 115.REST OF LAMEA EMPTY CAPSULE MARKET, BY RAW MATERIAL,2020-2030 ($MILLION)
  • TABLE 116.REST OF LAMEA EMPTY CAPSULE MARKET, BY THERAPEUTIC APPLICATION, 2020-2030 ($MILLION)
  • TABLE 117.REST OF LAMEA EMPTY CAPSULE MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 118.ACG: COMPANY SNAPSHOT
  • TABLE 119.ACG: PRODUCT SEGMENTS
  • TABLE 120.ACG: PRODUCT PORTFOLIO
  • TABLE 121.BRIGHT PHARMACAPS: COMPANY SNAPSHOT
  • TABLE 122.BRIGHT PHARMACAPS: PRODUCT PORTFOLIO
  • TABLE 123.CAPSCANADA: COMPANY SNAPSHOT
  • TABLE 124.CAPSCANADA: PRODUCT PORTFOLIO
  • TABLE 125.LONZA GROUP: COMPANY SNAPSHOT
  • TABLE 126.LONZA GROUP: OPERATING SEGMENTS
  • TABLE 127.LONZA GROUP: PRODUCT PORTFOLIO
  • TABLE 128.LONZA GROUP: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 129.MEDI-CAPS: COMPANY SNAPSHOT
  • TABLE 130.MEDI-CAPS: OPERATING SEGMENTS
  • TABLE 131.MEDI-CAPS: PRODUCT PORTFOLIO
  • TABLE 132.MITSUBISHI CHEMICAL: COMPANY SNAPSHOT
  • TABLE 133.MITSUBISHI CHEMICAL: OPERATING SEGMENTS
  • TABLE 134.MITSUBISHI CHEMICAL: PRODUCT PORTFOLIO
  • TABLE 135.MITSUBISHI CHEMICAL: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 136.ROXLOR: COMPANY SNAPSHOT
  • TABLE 137.ROXLOR: PRODUCT SEGMENTS
  • TABLE 138.ROXLOR: PRODUCT PORTFOLIO
  • TABLE 139.SNAIL PHARMA INDUSTRY: COMPANY SNAPSHOT
  • TABLE 140.SNAIL PHARMA INDUSTRY: PRODUCT SEGMENTS
  • TABLE 141.SNAIL PHARMA INDUSTRY: PRODUCT PORTFOLIO
  • TABLE 142.SUHEUNG CAPSULE: COMPANY SNAPSHOT
  • TABLE 143.SUHEUNG CAPSULE: PRODUCT PORTFOLIO
  • TABLE 144.SUNIL HEALTHCARE: COMPANY SNAPSHOT
  • TABLE 145.SUNIL HEALTHCARE: OPERATING SEGMENTS
  • TABLE 146.SUNIL HEALTHCARE: PRODUCT PORTFOLIO

LIST OF FIGURES

  • FIGURE 01.EMPTY CAPSULES MARKET SEGMENTATION
  • FIGURE 02.TOP INVESTMENT POCKETS
  • FIGURE 03.TOP WINNING STRATEGIES, BY YEAR, 2019-2021
  • FIGURE 04.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2019-2021
  • FIGURE 05.TOP WINNING STRATEGIES, BY COMPANY, 2019-2021
  • FIGURE 06.MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 07.MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 08.MODERATE THREAT OF SUBSTITUTES
  • FIGURE 09.HIGH THREAT OF NEW ENTRANTS
  • FIGURE 10.MODERATE INTENSITY OF RIVALRY
  • FIGURE 11.TOP PLAYER POSITIONING, 2020
  • FIGURE 12.IMPACT ANALYSIS
  • FIGURE 13.GELATIN CAPSULE MARKET, FOR HARD GELATIN CAPSULE (HGC), 2020-2030 ($MILLION)
  • FIGURE 14.GELATIN CAPSULE MARKET, FOR SOFT GELATIN CAPSULE (SGC)., 2020-2030 ($MILLION)
  • FIGURE 15.COMPARATIVE ANALYSIS OF GELATIN CAPSULE MARKET, BY COUNTRY, 2020-2030 (%)
  • FIGURE 16.COMPARATIVE ANALYSIS OF NON-GELATIN CAPSULE MARKET, BY COUNTRY, 2020-2030 (%)
  • FIGURE 17.COMPARATIVE ANALYSIS OF EMPTY CAPSULE MARKET FOR PIG MEAT, BY COUNTRY, 2020-2030 (%)
  • FIGURE 18.COMPARATIVE ANALYSIS OF EMPTY CAPSULE MARKET FOR BOVINE MEAT, BY COUNTRY, 2020-2030 (%)
  • FIGURE 19.COMPARATIVE ANALYSIS OF EMPTY CAPSULE MARKET FOR BONE, BY COUNTRY, 2020-2030 (%)
  • FIGURE 20.COMPARATIVE ANALYSIS OF EMPTY CAPSULE MARKET FOR HYDROXYPROPYL METHYLCELLULOSE (HPMC), BY COUNTRY, 2020-2030 (%)
  • FIGURE 21.COMPARATIVE ANALYSIS OF EMPTY CAPSULE MARKET FOR OTHERS, BY COUNTRY, 2020-2030 (%)
  • FIGURE 22.COMPARATIVE ANALYSIS OF EMPTY CAPSULE MARKET FOR ANTIBIOTIC & ANTIBACTERIAL DRUGS, BY COUNTRY, 2020-2030 (%)
  • FIGURE 23.COMPARATIVE ANALYSIS OF EMPTY CAPSULE MARKET FOR VITAMIN & DIETARY SUPPLEMENTS, BY COUNTRY, 2020-2030 (%)
  • FIGURE 24.COMPARATIVE ANALYSIS OF EMPTY CAPSULE MARKET FOR ANTACIDS & ANTI-FLATULENT PREPARATIONS, BY COUNTRY, 2020-2030 (%)
  • FIGURE 25.COMPARATIVE ANALYSIS OF EMPTY CAPSULE MARKET FOR CARDIAC THERAPY DRUGS, BY COUNTRY, 2020-2030 (%)
  • FIGURE 26.COMPARATIVE ANALYSIS OF EMPTY CAPSULE MARKET FOR OTHERS, BY COUNTRY, 2020-2030 (%)
  • FIGURE 27.COMPARATIVE ANALYSIS OF EMPTY CAPSULE MARKET FOR PHARMACEUTICAL MANUFACTURERS, BY COUNTRY, 2020-2030 (%)
  • FIGURE 28.COMPARATIVE ANALYSIS OF EMPTY CAPSULE MARKET FOR NUTRACEUTICAL MANUFACTURERS, BY COUNTRY, 2020-2030 (%)
  • FIGURE 29.COMPARATIVE ANALYSIS OF EMPTY CAPSULE MARKET FOR OTHERS, BY COUNTRY, 2020-2030 (%)
  • FIGURE 30.LONZA GROUP: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 31.LONZA GROUP: REVENUE SHARE BY SEGMENT, 2020 (%)
  • FIGURE 32.LONZA GROUP: REVENUE SHARE BY GEOGRAPHY, 2020 (%)
  • FIGURE 33.MEDI-CAPS: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 34.MITSUBISHI CHEMICAL: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 35.MITSUBISHI CHEMICAL: REVENUE SHARE BY SEGMENT, 2020 (%)
  • FIGURE 36.MITSUBISHI CHEMICAL: REVENUE SHARE BY GEOGRAPHY, 2020 (%)
  • FIGURE 37.SUNIL HEALTHCARE: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 38.SUNIL HEALTHCARE: REVENUE SHARE BY SEGMENT, 2020 (%)
  • FIGURE 39.SUNIL HEALTHCARE: REVENUE SHARE BY GEOGRAPHY, 2020 (%)

The global empty capsules market was valued at $2,382.7 million in 2020, and is projected to reach $5,230.4 million by 2030, registering a CAGR of 8.1% from 2021 to 2030.

Capsule is defined as the solid dosage in which active pharmaceutical ingredients (API) or inert substances are enclosed in soft or hard shell. Empty capsules are mostly made of gelatin. API is available in various formulations such as powder, semisolid mass, granules, and liquid. Capsules can be administered orally and vaginally. The capsule is easier to swallow as compared to other drug delivery forms such as a tablets.

Growth of the global empty capsules market is majorly driven by alarming increase in prevalence of chronic diseases such as cancer, cardiovascular diseases, diabetes, and gastrointestinal diseases; rise in government initiatives to spread awareness and promote advantages of nutraceuticals products; surge in number of capsule production; rise in expenditure on human healthcare services; and rise in adoption of gelatin capsules. For instance, according to the World Health Organization (WHO), in 2020, approximately 10 million deaths were reported due to cancer, globally. Healthcare supplements such as vitamin & minerals, herbs, and fibers are advised to patients having chemotherapy and radiation procedures to avoid side effects and strengthen their immune system. Moreover, in November 2021, ACG Capsules, one of the leading pharmaceutical companies, announced the launch of "ACG loves NOTHING", which is a global nutraceutical campaign and aimed to enhance nutraceutical production through industry leading innovation and collaboration strategy.

Rise in number of geriatric population and surge in demand for vitamin and mineral supplements drive growth of the market. Geriatric population is more vulnerable to chronic diseases and osteoarthritis disease, which surge demand for various drug therapies and vitamins& minerals for better health outcomes. This surges need for empty capsule production and is expected to propel growth of the market.

Increase in development of the pharmaceutical sector and surge in need for immunity booster supplements are major factors that drive the global empty capsules market. Moreover, increase in number of clinical studies significantly contributes toward the market growth. Clinical studies aim to evaluate safety and efficacy of drugs enclosed in capsule. Rise in number of capsule manufacturing acts as a key driving force for expansion of the global market. For instance, Lonza, a multinational chemical and biotechnology company produced 230 billion capsules in 2020. Furthermore, rise in funds by government and private organizations to develop capsule manufacturing units are expected to boost the market growth. For instance, in November 2021, ACG, announced that it will invest $78.00 million (Rs 600 crore) to develop Asia's largest capsule manufacturing unit in Maharashtra, India.

In addition, advancements in R&D activities in capsule drug delivery technology and rise in business expansion and partnership strategy are anticipated to provide lucrative opportunities for the market expansion. Moreover, in October 2020, Lonza, a multinational chemical and biotechnology company, announced the investment of $93 million in the capsule and health ingredients, which enable companies to expand its overall manufacturing capacity of capsule by 30 billion capsules, per year.

However, high cost of gelatin and lower availability of raw materials to manufacture gelatin are anticipated to hinder the market growth. On the contrary, rise in number of capsule manufacturing units, advancements of technology for development of wide range of range having different flavor, color &size, and increase in awareness among population about nutraceutical products augment growth of the empty capsules sector. This has further encouraged many key players to enter emerging markets, thus offering lucrative opportunities in the empty capsules market.

The global empty capsules market is segmented into product, raw material, therapeutic application, end user, and region. By product, the market is categorized into gelatin capsules and non-gelatin capsules. The gelatin capsules segment is further divided into hard gelatin capsules (HGC) and soft gelatin capsules (SGC). On the basis of raw material, it is categorized into pig meat, bovine meat, bone, hydroxypropyl methylcellulose (HPMC), and others.

Depending on therapeutic application, it is fragmented into antibiotic & antibacterial drugs, vitamin & dietary supplements, antacids & anti-flatulent preparations, cardiac therapy drugs, and others. Depending on end user, it is fragmented into pharmaceutical manufacturers, nutraceutical manufacturers, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Some of the major companies that operate in the global empty capsules market are ACG Worldwide, Bright Pharma Caps Inc., CapsCanada Corporation, Lonza Group Ltd. (Capsugel), Medi-Caps Ltd., Mitsubishi Chemical Holdings Corporation (Qualicaps, Inc.), Roxlor LLC, Snail Pharma Industry Co. Ltd, Suheung Co., Ltd, and Sunil Healthcare Ltd.

KEY BENEFITS FOR STAKEHOLDERS

  • The report provides an in-depth analysis of the global empty capsules market size along with the current trends and future estimations to elucidate the imminent investment pockets.
  • It offers market analysis from 2021 to 2030, which is expected to enable the stakeholders to capitalize on the prevailing opportunities in the market.
  • A comprehensive analysis on region assists to understand the regional market and facilitate the strategic business planning and determine prevailing opportunities.
  • The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global empty capsules market.

KEY MARKET SEGMENTS

By Product

  • Gelatin Capsules
  • Non-Gelatin Capsules

By Raw Material

  • Pig Meat
  • Bovine Meat
  • Bone
  • Hydroxypropyl Methylcellulose (HPMC)
  • Others

By Therapeutic Application

  • Antibiotic & Antibacterial Drugs
  • Vitamin & Dietary Supplements
  • Antacids & Anti-Flatulent Preparations
  • Cardiac Therapy Drugs
  • Others

By End User

  • Pharmaceutical Manufacturers
  • Nutraceutical Manufacturers
  • Others

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • Australia
  • India
  • South Korea
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

KEY MARKET PLAYERS

  • ACG Worldwide
  • Bright Pharma Caps Inc.
  • CapsCanada Corporation
  • Lonza Group Ltd. (Capsugel)
  • Medi-Caps Ltd.
  • Mitsubishi Chemical Holdings Corporation (Qualicaps, Inc.)
  • Roxlor LLC
  • Snail Pharma Industry Co. Ltd
  • Suheung Co., Ltd
  • Sunil Healthcare Ltd.

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

  • 1.1.Report description
  • 1.2.Key benefits for stakeholders
  • 1.3.Key market segments
  • 1.4.Research methodology
    • 1.4.1.Secondary research
    • 1.4.2.Primary research
    • 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

  • 2.1.Key findings of the study
  • 2.2.CXO perspective

CHAPTER 3:MARKET LANDSCAPE

  • 3.1.Market definition and scope
  • 3.2.Key findings
    • 3.2.1.Top investment pockets
    • 3.2.2.Top winning strategies
  • 3.3.Porter's five forces analysis
  • 3.4.Top player positioning, 2020
  • 3.5.Market dynamics
    • 3.5.1.Drivers
      • 3.5.1.1.Increase in prevalence of chronic diseases
      • 3.5.1.2.Increase in number of empty capsules production
      • 3.5.1.3.Advancements in technology to develop capsules
    • 3.5.2.Restraints
      • 3.5.2.1.Ethical concerns along with price fluctuations regarding gelatin material
      • 3.5.2.2.Stringent regulations in the pharmaceutical industry
    • 3.5.3.Opportunities
      • 3.5.3.1.Development of pharmaceutical industry and rise in healthcare expenditure
    • 3.5.4.Impact analysis
  • 3.6.Impact analysis of COVID-19 on the empty capsules market

CHAPTER 4:EMPTY CAPSULE MARKET, BY PRODUCT

  • 4.1.Overview
    • 4.1.1.Market size and forecast
  • 4.2.Gelatin capsules
    • 4.2.1.Key market trends, growth factors, and opportunities
    • 4.2.2.Gelatin Capsule, by Type
      • 4.2.2.1.Market size and forecast
      • 4.2.2.2.Hard gelatin capsule (HGC)
      • 4.2.2.2.1.Market size and forecast
      • 4.2.2.3.Soft gelatin capsule (SGC)
      • 4.2.2.3.1.Market size and forecast
    • 4.2.3.Market size and forecast, by region
    • 4.2.4.Market analysis, by country
  • 4.3.Non-gelatin capsules
    • 4.3.1.Key market trends, growth factors, and opportunities
    • 4.3.2.Market size and forecast, by region
    • 4.3.3.Market analysis, by country

CHAPTER 5:EMPTY CAPSULE MARKET, BY RAW MATERIAL

  • 5.1.Overview
    • 5.1.1.Market size and forecast
  • 5.2.Pig Meat
    • 5.2.1.Key market trends, growth factors, and opportunities
    • 5.2.2.Market size and forecast, by region
    • 5.2.3.Market analysis, by country
  • 5.3.Bovine meat
    • 5.3.1.Key market trends, growth factors, and opportunities
    • 5.3.2.Market size and forecast, by region
    • 5.3.3.Market analysis, by country
  • 5.4.Bone
    • 5.4.1.Key market trends, growth factors, and opportunities
    • 5.4.2.Market size and forecast, by region
    • 5.4.3.Market analysis, by country
  • 5.5.Hydroxypropyl methylcellulose (HPMC)
    • 5.5.1.Key market trends, growth factors, and opportunities
    • 5.5.2.Market size and forecast, by region
    • 5.5.3.Market analysis, by country
  • 5.6.Others
    • 5.6.1.Key market trends, growth factors, and opportunities
    • 5.6.2.Market size and forecast, by region
    • 5.6.3.Market analysis, by country

CHAPTER 6:EMPTY CAPSULE MARKET, BY THERAPEUTIC APPILICATION

  • 6.1.Overview
    • 6.1.1.Market size and forecast
  • 6.2.Antibiotic & Antibacterial Drugs
    • 6.2.1.Key market trends, growth factors, and opportunities
    • 6.2.2.Market size and forecast, by region
    • 6.2.3.Market analysis, by country
  • 6.3.Vitamin & dietary supplements
    • 6.3.1.Key market trends, growth factors, and opportunities
    • 6.3.2.Market size and forecast, by region
    • 6.3.3.Market analysis, by country
  • 6.4.Antacids & anti-flatulent preparations
    • 6.4.1.Key market trends, growth factors, and opportunities
    • 6.4.2.Market size and forecast, by region
    • 6.4.3.Market analysis, by country
  • 6.5.Cardiac therapy drugs
    • 6.5.1.Key market trends, growth factors, and opportunities
    • 6.5.2.Market size and forecast, by region
    • 6.5.3.Market analysis, by country
  • 6.6.Others
    • 6.6.1.Key market trends, growth factors, and opportunities
    • 6.6.2.Market size and forecast, by region
    • 6.6.3.Market analysis, by country

CHAPTER 7:EMPTY CAPSULE MARKET, BY END USER

  • 7.1.Overview
    • 7.1.1.Market size and forecast
  • 7.2.Pharmaceutical manufacturers
    • 7.2.1.Key market trends, growth factors, and opportunities
    • 7.2.2.Market size and forecast, by region
    • 7.2.3.Market analysis, by country
  • 7.3.Nutraceutical manufacturers
    • 7.3.1.Key market trends, growth factors, and opportunities
    • 7.3.2.Market size and forecast, by region
    • 7.3.3.Market analysis, by country
  • 7.4.Others
    • 7.4.1.Key market trends, growth factors, and opportunities
    • 7.4.2.Market size and forecast, by region
    • 7.4.3.Market analysis, by country

CHAPTER 8:EMPTY CAPSULE MARKET, BY REGION

  • 8.1.Overview
    • 8.1.1.Market size and forecast
  • 8.2.North America
    • 8.2.1.Key market trends, growth factors, and opportunities
    • 8.2.2.North America emptycapsule market, by product
    • 8.2.3.North America empty capsule market, by raw material
    • 8.2.4.North America emptycapsule market, by therapeutic application
    • 8.2.5.North America emptycapsule market, by end user
    • 8.2.6.Market size and forecast, by country
      • 8.2.6.1.U.S.
      • 8.2.6.1.1.U.S. empty capsule market, by product
      • 8.2.6.1.2.U.S. empty capsule market, by raw material
      • 8.2.6.1.3.U.S. empty capsule market, by therapeutic application
      • 8.2.6.1.4.U.S. empty capsule market, by end user
      • 8.2.6.2.Canada
      • 8.2.6.2.1.Canada empty capsule market, by product
      • 8.2.6.2.2.Canada empty capsule market, by raw material
      • 8.2.6.2.3.Canada empty capsule market, by therapeutic application
      • 8.2.6.2.4.Canada empty capsule market, by end user
      • 8.2.6.3.Mexico
      • 8.2.6.3.1.Mexico empty capsule market, by product
      • 8.2.6.3.2.Mexico empty capsule market, by raw material
      • 8.2.6.3.3.Mexico empty capsule market, by therapeutic application
      • 8.2.6.3.4.Mexico empty capsule market, by end user
  • 8.3.Europe
    • 8.3.1.Key market trends, growth factors, and opportunities
    • 8.3.2.Europe empty capsule market, by product
    • 8.3.3.Europe empty capsule market, by raw material
    • 8.3.4.Europe empty capsule market, by therapeutic application
    • 8.3.5.Europe empty capsule market, by end user
    • 8.3.6.Market size and forecast, by country
      • 8.3.6.1.Germany
      • 8.3.6.1.1.Germany empty capsule market, by product
      • 8.3.6.1.2.Germany empty capsule market, by raw material
      • 8.3.6.1.3.Germany empty capsule market, by therapeutic application
      • 8.3.6.1.4.Germany empty capsule market, by end user
      • 8.3.6.2.France
      • 8.3.6.2.1.France empty capsule market, by product
      • 8.3.6.2.2.France empty capsule market, by raw material
      • 8.3.6.2.3.France empty capsule market, by therapeutic application
      • 8.3.6.2.4.France empty capsule market, by end user
      • 8.3.6.3.UK
      • 8.3.6.3.1.UK empty capsule market, by product
      • 8.3.6.3.2.UK empty capsule market, by raw material
      • 8.3.6.3.3.UK empty capsule market, by therapeutic application
      • 8.3.6.3.4.UK empty capsule market, by end user
      • 8.3.6.4.Italy
      • 8.3.6.4.1.Italy empty capsule market, by product
      • 8.3.6.4.2.Italy empty capsule market, by raw material
      • 8.3.6.4.3.Italy empty capsule market, by therapeutic application
      • 8.3.6.4.4.Italy empty capsule market, by end user
      • 8.3.6.5.Spain
      • 8.3.6.5.1.Spain empty capsule market, by product
      • 8.3.6.5.2.Spain empty capsule market, by raw material
      • 8.3.6.5.3.Spain empty capsule market, by therapeutic application
      • 8.3.6.5.4.Spain empty capsule market, by end user
      • 8.3.6.6.Rest of Europe
      • 8.3.6.6.1.Rest of Europe empty capsule market, by product
      • 8.3.6.6.2.Rest of Europe empty capsule market, by raw material
      • 8.3.6.6.3.Rest of Europe empty capsule market, by therapeutic application
      • 8.3.6.6.4.Rest of Europe empty capsule market, by end user
  • 8.4.Asia-Pacific
    • 8.4.1.Key market trends, growth factors, and opportunities
    • 8.4.2.Asia-Pacific empty capsule market, by product
    • 8.4.3.Asia-Pacific empty capsule market, by raw material
    • 8.4.4.Asia-Pacific empty capsule market, by therapeutic application
    • 8.4.5.Asia-Pacific empty capsule market, by end user
    • 8.4.6.Market size and forecast, by country
      • 8.4.6.1.Japan
      • 8.4.6.1.1.Japan empty capsule market, by product
      • 8.4.6.1.2.Japan empty capsule market, by raw material
      • 8.4.6.1.3.Japan empty capsule market, by therapeutic application
      • 8.4.6.1.4.Japan empty capsule market, by end user
      • 8.4.6.2.China
      • 8.4.6.2.1.China empty capsule market, by product
      • 8.4.6.2.2.China empty capsule market, by raw material
      • 8.4.6.2.3.China empty capsule market, by therapeutic application
      • 8.4.6.2.4.China empty capsule market, by end user
      • 8.4.6.3.Australia
      • 8.4.6.3.1.Australia emptycapsule market, by product
      • 8.4.6.3.2.Australia empty capsule market, by raw material
      • 8.4.6.3.3.Australia empty capsule market, by therapeutic application
      • 8.4.6.3.4.Australia empty capsule market, by end user
      • 8.4.6.4.India
      • 8.4.6.4.1.India empty capsule market, by product
      • 8.4.6.4.2.India empty capsule market, by raw material
      • 8.4.6.4.3.India empty capsule market, by therapeutic application
      • 8.4.6.4.4.India empty capsule market, by end user
      • 8.4.6.5.South Korea
      • 8.4.6.5.1.South Korea empty capsule market, by product
      • 8.4.6.5.2.South Korea empty capsule market, by raw material
      • 8.4.6.5.3.South Korea empty capsule market, by therapeutic application
      • 8.4.6.5.4.South Korea empty capsule market, by end user
      • 8.4.6.6.Rest of Asia-Pacific
      • 8.4.6.6.1.Rest of Asia-Pacific empty capsule market, by product
      • 8.4.6.6.2.Rest of Asia-Pacific empty capsule market, by raw material
      • 8.4.6.6.3.Rest of Asia-Pacific empty capsule market, by therapeutic application
      • 8.4.6.6.4.Rest of Asia-Pacific empty capsule market, by end user
  • 8.5.LAMEA
    • 8.5.1.Key market trends, growth factors, and opportunities
    • 8.5.2.LAMEA empty capsule market, by product
    • 8.5.3.LAMEA empty capsule market, by raw material
    • 8.5.4.LAMEA empty capsule market, by therapeutic application
    • 8.5.5.LAMEA empty capsule market, by end user
    • 8.5.6.Market size and forecast, by country
      • 8.5.6.1.Brazil
      • 8.5.6.1.1.Brazil empty capsule market, by product
      • 8.5.6.1.2.Brazil empty capsule market, by raw material
      • 8.5.6.1.3.Brazil empty capsule market, by therapeutic application
      • 8.5.6.1.4.Brazil empty capsule market, by end user
      • 8.5.6.2.Saudi Arabia
      • 8.5.6.2.1.Saudi Arabia empty capsule market, by product
      • 8.5.6.2.2.Saudi Arabia empty capsule market, by raw material
      • 8.5.6.2.3.Saudi Arabia empty capsule market, by therapeutic application
      • 8.5.6.2.4.Saudi Arabia empty capsule market, by end user
      • 8.5.6.3.South Africa
      • 8.5.6.3.1.South Africa emptycapsule market, by product
      • 8.5.6.3.2.South Africa empty capsule market, by raw material
      • 8.5.6.3.3.South Africa empty capsule market, by therapeutic application
      • 8.5.6.3.4.South Africa empty capsule market, by end user
      • 8.5.6.4.Rest of LAMEA
      • 8.5.6.4.1.Rest of LAMEA empty capsule market, by product
      • 8.5.6.4.2.Rest of LAMEA empty capsule market, by raw material
      • 8.5.6.4.3.Rest of LAMEA empty capsule market, by therapeutic application
      • 8.5.6.4.4.Rest of LAMEA empty capsule market, by end user

CHAPTER 9:COMPANY PROFILES

  • 9.1.ACG Worldwide
    • 9.1.1.Company overview
    • 9.1.2.Company snapshot
    • 9.1.3.Operating business segments
    • 9.1.4.Product portfolio
  • 9.2.Bright Pharma Caps Inc.
    • 9.2.1.Company overview
    • 9.2.2.Company snapshot
    • 9.2.3.Product portfolio
  • 9.3.CapsCanada Corporation
    • 9.3.1.Company overview
    • 9.3.2.Company snapshot
    • 9.3.3.Product portfolio
  • 9.4.Lonza Group Ltd. (Capsugel)
    • 9.4.1.Company overview
    • 9.4.2.Company snapshot
    • 9.4.3.Operating business segments
    • 9.4.4.Product portfolio
    • 9.4.5.Business performance
    • 9.4.6.Key strategic moves and developments
  • 9.5.Medi-Caps Limited
    • 9.5.1.Company overview
    • 9.5.2.Company snapshot
    • 9.5.3.Operating business segments
    • 9.5.4.Product portfolio
    • 9.5.5.Business performance
  • 9.6.Mitsubishi Chemical Holdings Corporation (Qualicaps, Inc.)
    • 9.6.1.Company overview
    • 9.6.2.Company snapshot
    • 9.6.3.Operating business segments
    • 9.6.4.Product portfolio
    • 9.6.5.Business performance
    • 9.6.6.Key strategic moves and developments
  • 9.7.Roxlor LLC
    • 9.7.1.Company overview
    • 9.7.2.Company snapshot
    • 9.7.3.Operating business segments
    • 9.7.4.Product portfolio
  • 9.8.Snail Pharma Industry Co. Ltd.
    • 9.8.1.Company overview
    • 9.8.2.Company snapshot
    • 9.8.3.Operating business segments
    • 9.8.4.Product portfolio
  • 9.9.Suheung Co., Ltd.
    • 9.9.1.Company overview
    • 9.9.2.Company snapshot
    • 9.9.3.Product portfolio
  • 9.10.Sunil Healthcare Ltd.
    • 9.10.1.Company overview
    • 9.10.2.Company snapshot
    • 9.10.3.Operating business segments
    • 9.10.4.Product portfolio
    • 9.10.5.Business performance
Back to Top
전화 문의
F A Q